Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.

Bailón L, Llano A, Cedeño S, Escribà T, Rosás-Umbert M, Parera M, Casadellà M, Lopez M, Pérez F, Oriol-Tordera B, Ruiz-Riol M, Coll J, Perez F, Rivero À, Leselbaum AR, McGowan I, Sengupta D, Wee EG, Hanke T, Paredes R, Alarcón-Soto Y, Clotet B, Noguera-Julian M, Brander C, Molto J, Mothe B, AELIX002 Study Group

Open source

DOI: 10.1038/s41591-022-02060-2
Published: 2022 Dec
Container: Nature medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-022-02060-2,
  title = {Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.},
  author = {Bailón L and Llano A and Cedeño S and Escribà T and Rosás-Umbert M and Parera M and Casadellà M and Lopez M and Pérez F and Oriol-Tordera B and Ruiz-Riol M and Coll J and Perez F and Rivero À and Leselbaum AR and McGowan I and Sengupta D and Wee EG and Hanke T and Paredes R and Alarcón-Soto Y and Clotet B and Noguera-Julian M and Brander C and Molto J and Mothe B and AELIX002 Study Group},
  year = {2022},
  journal = {Nature medicine},
  doi = {10.1038/s41591-022-02060-2},
  url = {https://doi.org/10.1038/s41591-022-02060-2}
}

RIS

TY  - JOUR
TI  - Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
AU  - Bailón L
AU  - Llano A
AU  - Cedeño S
AU  - Escribà T
AU  - Rosás-Umbert M
AU  - Parera M
AU  - Casadellà M
AU  - Lopez M
AU  - Pérez F
AU  - Oriol-Tordera B
AU  - Ruiz-Riol M
AU  - Coll J
AU  - Perez F
AU  - Rivero À
AU  - Leselbaum AR
AU  - McGowan I
AU  - Sengupta D
AU  - Wee EG
AU  - Hanke T
AU  - Paredes R
AU  - Alarcón-Soto Y
AU  - Clotet B
AU  - Noguera-Julian M
AU  - Brander C
AU  - Molto J
AU  - Mothe B
AU  - AELIX002 Study Group
PY  - 2022
JO  - Nature medicine
DO  - 10.1038/s41591-022-02060-2
UR  - https://doi.org/10.1038/s41591-022-02060-2
ER  -

APA

L, B., A, L., S, C., T, E., M, R., M, P., M, C., M, L., F, P., B, O., M, R., J, C., F, P., À, R., AR, L., I, M., D, S., EG, W., T, H., R, P., Y, A., B, C., M, N., C, B., J, M., B, M., & Group, A. S. (2022). Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.. Nature medicine. https://doi.org/10.1038/s41591-022-02060-2

Source records

pubmed · retrieved 2026-09-26T22:39:09.697Z